A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period
2007 ◽
Vol 61
(3)
◽
pp. 515-524
◽
1993 ◽
Vol 29
(7)
◽
pp. 983-988
◽
1994 ◽
Vol 85
(10)
◽
pp. 1057-1062
◽
2003 ◽
Vol 39
(13)
◽
pp. 1842-1851
◽